Physician profile
Abraham Rothman
NPI 1730162074
$174,678.08
in general payments reported to CMS, 2019-2025
9 companies · $67K in 2025
The $67K reported for 2025 was more than what 99% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $39.76 · 2021: $2,812 · 2022: $7,187 · 2023: $14K · 2024: $84K · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $121K · Travel and Lodging: $27K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $2,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $121,237.50 |
| Travel and Lodging | $27,276.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,750.00 |
| Food and Beverage | $2,188.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $172,331.06 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Abbott Laboratories | $1,103.31 | 2020-2025 | Amplatzer Piccolo, Amplatzer, Amplatzer Talisman |
| Medtronic, INC. | $648.25 | 2021-2023 | Harmony |
| Actelion Pharmaceuticals US, INC. | $276.40 | 2019-2024 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $142.65 | 2024-2025 | Winrevair |
| E.R. Squibb & Sons, L.L.C. | $116.60 | 2023 | Camzyos |
| Gilead Sciences, INC. | $39.11 | 2019 | |
| Angiodynamics, INC. | $20.70 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Rothman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.